קרישה

Coagulation is the final phase of hemostasis, involving a series of chemical reactions that form a blood clot to reinforce the initial platelet plug. This process creates an insoluble fibrin mesh that captures blood cells and platelets, permanently sealing vascular injuries. Coagulation typically completes within 3 to 6 minutes, preventing further blood loss after vessel damage.

The extrinsic and intrinsic pathways of hemostasis are two cascade routes that converge to form the prothrombin activator complex. This complex facilitates the conversion of prothrombin into thrombin, a critical enzyme that converts fibrinogen into fibrin fibers. Both pathways work together to initiate the common pathway reactions necessary for complete clot formation.

Thrombin is an enzyme produced when prothrombin activator converts prothrombin in the blood. Once activated, thrombin catalyzes the conversion of fibrinogen into insoluble fibrin fibers. These fibers polymerize to form a mesh-like structure that traps blood cells and platelets, creating the structural foundation of the blood clot.

Fibrin is produced when thrombin converts fibrinogen, a soluble protein in blood plasma, into insoluble fibrin. The fibrin fibers polymerize to create a mesh-like lattice that captures blood cells, platelets, and plasma components. These fibers also adhere to damaged blood vessel surfaces, creating a stable clot that seals the injury and prevents blood loss.

The prothrombin activator is an activated complex formed by the convergence of extrinsic and intrinsic pathway reactions. Its primary function is to catalyze the conversion of prothrombin into thrombin, initiating the common pathway of coagulation. This transformation is essential for triggering the downstream enzymatic reactions that ultimately produce fibrin and stabilize the blood clot.

Coagulation begins within 15 to 20 seconds after severe vascular damage or 1 to 2 minutes after minor injuries. The complete clot formation typically takes 3 to 6 minutes to fully seal the vascular wound, assuming the vessel opening is not excessively large. This rapid response prevents significant blood loss and stabilizes the injury site.

Key clotting factors, or procoagulants, include fibrinogen, prothrombin, tissue factor, calcium, and thrombin, each playing a unique role in the coagulation cascade. These factors work sequentially through extrinsic, intrinsic, and common pathways to convert fibrinogen into fibrin and form the blood clot. Their coordinated action ensures efficient hemostasis and prevents excessive bleeding.